| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Upstream Bio, Inc. (UPB) has 11 insiders with recent SEC Form 4 filings, including 5 buys and 5 sells. UPB is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 70.8K | $442.6K | -2,095 | |
| Other | 33.2K | $207.5K | -895 | |
| CFO | 28.8K | $180.0K | -853 | |
| Other | 23.6K | $147.5K | -700 | |
| Dir | 17.1K | $106.8K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 16, 2026 | Sutherland Everett Rand | Chief Executive Officer | Sell | 2,095 | $6.10 | $12,779.50 | -2.9% | - | - | |
| Jun 16, 2026 | Houghton Adam | Chief Business Officer | Sell | 700 | $6.10 | $4,270.00 | -2.9% | - | - | |
| Jun 16, 2026 | Gray Michael | CFO And COO | Sell | 853 | $6.10 | $5,203.30 | -2.9% | - | - | |
| Jun 16, 2026 | Deykin Aaron | Chief Medical Officer | Sell | 895 | $6.10 | $5,459.50 | -2.6% | - | - | |
| Jun 16, 2026 | Ambrose Allison | General Counsel | Sell | 477 | $6.10 | $2,909.70 | -2.9% | - | - | |
| Oct 15, 2024 | Ai Upstream LLC | 10% Owner | Buy | 1,175,000 | $17.00 | $19,975,000.00 | New | -50.3% | -5.7% | |
| Oct 15, 2024 | Orbimed Advisors LLC67 | Director, 10% Owner | Buy | 825,000 | $17.00 | $14,025,000.00 | +16.9% | -50.3% | -5.7% | |
| Oct 15, 2024 | Chimovits Erez | Director, 10% Owner | Buy | 825,000 | $17.00 | $14,025,000.00 | +16.9% | -50.3% | -5.7% |